Product Code: 138127-01-23
Postpartum Hemorrhage (PPH) Treatment Devices Market Expected to Grow at 4.5% by 2031. The key factor that drives the postpartum hemorrhage devices market growth includes increase in complications in pregnancy, including large size baby, inverted uterus, and multiple pregnancies. Moreover, rise in PPH risk factors, such as uterine atony and trauma; growth in anemia cases in pregnant women; and surge in awareness regarding PPH risk factors boost the growth during postpartum hemorrhage devices market forecast.
Despite being a preventable and treatable condition, postpartum hemorrhage (PPH) the leading direct cause of maternal deaths worldwide. However, women in low respurce stings may not have desired access to appropriate care. This condition causes approximately 25% of the total maternal deaths. PPH is defined as excessive vaginal bleeding and occurs in over 10% of the total births and is linked with 1% case fatality rate. Active management of third stage labor can prevent up to 60% PPH cases, it still has devastating effect in low-income countries. Currently PPH causes approximately 34% and 31% of maternal deaths in Africa and Asia, whereas 31% in Caribbean and Latin America. A majority of primary PPH cases are caused byb uterine atony and result in prolonged labor, and preclampsia.
Among the available products for treating PPH, uterine balloon tamponades segment currently experiences the highest demand. Better effectiveness, ease of use and wide availability are the key factors contributing to the dominance of this segment. Additionally, the demand for uniject prefilled injection systems is expected to be the highest during the forecast period. Ease of application, greater support from governments and convenient pricing mainly support the rapid growth of this segment. On the other hand, non-pneumatic anti-shock garment (NASG) segment will undergo satisfactorily fast market growth during the forecast period.
North America currently holds over 30% of the global share thereby dominating the market. Higher hospital birth rates, greater awareness among patients and healthcare providers and favorable government policies fuel the lead of North America market. The demand for PPH treatment devices will be the highest in Asia Pacific due to greater population pool and and swift evolution of healthare infrastructure. Additionally, increase in the number of welfare initiatives undertaken by governments for augmenting hospital births and preventing maternal deaths will also assist in boosting the demand for novel PPH treatment devices during the forecast period.
Some key players identified for Postpartum Hemorrhage Treatment Devices market include:
C. R. Bard, Inc., Cook Medical, Inc., Becton Dickinson and Company, Teleflex Incorporated, Bactiguard AB, Utah Medical Products Inc., 3rd Stone Design, Bactiguard AB, Becton, Dickinson and Company Clinical Innovations, LLC., Cook, Obstetrx, Organon, Path, Teleflex Incorporated, and Utah Medical Products, Inc and others.
Historical & Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Postpartum Hemorrhage (PPH) Treatment Devices market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report:
Micro and macro environment factors that are currently influencing the Postpartum Hemorrhage (PPH) Treatment Devices market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Product
Uterine balloon tamponade
Bakri balloon tamponade
Condom catheter
Foley catheter
BT-Cath balloon
Uniject prefilled injection system
Non-pneumatic anti-shock garment (NASG)
Region Segment (2021-2031; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Global Impact of COVID-19 Segment (2020-2021; US$ Million )
Pre COVID-19 situation
Post COVID-19 situation
Key questions answered in this report:
What are the key micro and macro environmental factors that are impacting the growth of Postpartum Hemorrhage (PPH) Treatment Devices market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2031.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Postpartum Hemorrhage (PPH) Treatment Devices market?
Which is the largest regional market for Postpartum Hemorrhage (PPH) Treatment Devices market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Postpartum Hemorrhage (PPH) Treatment Devices market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Postpartum Hemorrhage (PPH) Treatment Devices market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Postpartum Hemorrhage (PPH) Treatment Devices Market
- 2.2. Global Postpartum Hemorrhage (PPH) Treatment Devices Market, By Product, 2021 (US$ Million)
- 2.3. Global Postpartum Hemorrhage (PPH) Treatment Devices Market, By Geography, 2021 (US$ Million)
- 2.4. Attractive Investment Proposition by Geography, 2021
3. Postpartum Hemorrhage (PPH) Treatment Devices Market: Competitive Analysis
- 3.1. Market Positioning of Key Postpartum Hemorrhage (PPH) Treatment Devices Market Vendors
- 3.2. Strategies Adopted by Postpartum Hemorrhage (PPH) Treatment Devices Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2021 Versus 2030
4. Postpartum Hemorrhage (PPH) Treatment Devices Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Postpartum Hemorrhage (PPH) Treatment Devices Market Value, 2020 - 2030, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
5. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2021 Versus 2030
- 5.3. Market Segmentation
- 5.3.1. Uterine balloon tamponade
- 5.3.1.1. Bakri balloon tamponade
- 5.3.1.2. Condom catheter
- 5.3.1.3. Foley catheter
- 5.3.1.4. BT-Cath balloon
- 5.3.2. Uniject prefilled injection system
- 5.3.3. Non-pneumatic anti-shock garment (NASG)
6. North America Postpartum Hemorrhage (PPH) Treatment Devices Market, 2020-2030, USD (Million)
- 6.1. Market Overview
- 6.2. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 6.3.Postpartum Hemorrhage (PPH) Treatment Devices Market: By Region, 2020-2030, USD (Million)
- 6.3.1.North America
- 6.3.1.1. U.S.
- 6.3.1.1.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 6.3.1.2. Canada
- 6.3.1.2.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 6.3.1.3. Rest of North America
- 6.3.1.3.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
7. UK and European Union Postpartum Hemorrhage (PPH) Treatment Devices Market, 2020-2030, USD (Million)
- 7.1. Market Overview
- 7.2. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 7.3.Postpartum Hemorrhage (PPH) Treatment Devices Market: By Region, 2020-2030, USD (Million)
- 7.3.1.UK and European Union
- 7.3.1.1. UK
- 7.3.1.1.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 7.3.1.2. Germany
- 7.3.1.2.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 7.3.1.3. Spain
- 7.3.1.3.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 7.3.1.4. Italy
- 7.3.1.4.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 7.3.1.5. France
- 7.3.1.5.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 7.3.1.6. Rest of Europe
- 7.3.1.6.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
8. Asia Pacific Postpartum Hemorrhage (PPH) Treatment Devices Market, 2020-2030, USD (Million)
- 8.1. Market Overview
- 8.2. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 8.3.Postpartum Hemorrhage (PPH) Treatment Devices Market: By Region, 2020-2030, USD (Million)
- 8.3.1.Asia Pacific
- 8.3.1.1. China
- 8.3.1.1.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 8.3.1.2. Japan
- 8.3.1.2.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 8.3.1.3. India
- 8.3.1.3.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 8.3.1.4. Australia
- 8.3.1.4.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 8.3.1.5. South Korea
- 8.3.1.5.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 8.3.1.6. Rest of Asia Pacific
- 8.3.1.6.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
9. Latin America Postpartum Hemorrhage (PPH) Treatment Devices Market, 2020-2030, USD (Million)
- 9.1. Market Overview
- 9.2. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 9.3.Postpartum Hemorrhage (PPH) Treatment Devices Market: By Region, 2020-2030, USD (Million)
- 9.3.1.Latin America
- 9.3.1.1. Brazil
- 9.3.1.1.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 9.3.1.2. Mexico
- 9.3.1.2.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 9.3.1.3. Rest of Latin America
- 9.3.1.3.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
10. Middle East and Africa Postpartum Hemorrhage (PPH) Treatment Devices Market, 2020-2030, USD (Million)
- 10.1. Market Overview
- 10.2. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 10.3.Postpartum Hemorrhage (PPH) Treatment Devices Market: By Region, 2020-2030, USD (Million)
- 10.3.1.Middle East and Africa
- 10.3.1.1. GCC
- 10.3.1.1.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 10.3.1.2. Africa
- 10.3.1.2.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
- 10.3.1.3. Rest of Middle East and Africa
- 10.3.1.3.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
11. Company Profile
- 11.1. C. R. Bard, Inc.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Portfolio
- 11.1.4. Strategic Initiatives
- 11.2. Cook Medical, Inc.,
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Portfolio
- 11.2.4. Strategic Initiatives
- 11.3. Becton Dickinson and Company
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Portfolio
- 11.3.4. Strategic Initiatives
- 11.4. Teleflex Incorporated
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Portfolio
- 11.4.4. Strategic Initiatives
- 11.5. Bactiguard AB
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Portfolio
- 11.5.4. Strategic Initiatives
- 11.6. Utah Medical Products Inc.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Portfolio
- 11.6.4. Strategic Initiatives
- 11.7. rd Stone Design
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Portfolio
- 11.7.4. Strategic Initiatives
- 11.8. Bactiguard AB
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Portfolio
- 11.8.4. Strategic Initiatives
- 11.9. Becton
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Portfolio
- 11.9.4. Strategic Initiatives
- 11.10. Dickinson and Company
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Portfolio
- 11.10.4. Strategic Initiatives
- 11.11. Clinical Innovations, LLC.
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Portfolio
- 11.11.4. Strategic Initiatives
- 11.12. Cook
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Portfolio
- 11.12.4. Strategic Initiatives
- 11.13. Obstetrx
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Portfolio
- 11.13.4. Strategic Initiatives
- 11.14. Organon
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Portfolio
- 11.14.4. Strategic Initiatives
- 11.15. Path
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Portfolio
- 11.15.4. Strategic Initiatives
- 11.16. Teleflex Incorporated
- 11.16.1. Company Overview
- 11.16.2. Financial Performance
- 11.16.3. Product Portfolio
- 11.16.4. Strategic Initiatives
- 11.17. Utah Medical Products, Inc
- 11.17.1. Company Overview
- 11.17.2. Financial Performance
- 11.17.3. Product Portfolio
- 11.17.4. Strategic Initiatives
- 11.18. Others
- 11.18.1. Company Overview
- 11.18.2. Financial Performance
- 11.18.3. Product Portfolio
- 11.18.4. Strategic Initiatives